Prostate‐specific antigen nadir and testosterone level at prostate‐specific antigen failure following radiation and androgen suppression therapy for unfavorable‐risk prostate cancer and the risk of all‐cause and prostate cancer–specific mortality-Reference-Cited by-同舟云学术

Prostate‐specific antigen nadir and testosterone level at prostate‐specific antigen failure following radiation and androgen suppression therapy for unfavorable‐risk prostate cancer and the risk of all‐cause and prostate cancer–specific mortality

Published:2021-04-06 Issue:15 Volume:127 Page:2623-2630
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Bitterman Danielle S.¹²^ORCID,Chen Ming‐Hui³^ORCID,Wu Jing⁴,Renshaw Andrew A.⁵,Loffredo Marian²,Kantoff Philip W.⁶,Small Eric J.⁷,D'Amico Anthony V.²

Affiliation:

1. Harvard Radiation Oncology Program Dana‐Farber Cancer Institute and Brigham and Women's Hospital Boston Massachusetts

2. Department of Radiation Oncology Dana‐Farber Cancer Institute and Brigham and Women's Hospital Boston Massachusetts

3. Department of Statistics University of Connecticut Storrs Connecticut

4. Department of Computer Science and Statistics University of Rhode Island Kingston Rhode Island

5. Department of Pathology Baptist Hospital and Miami Cancer Institute Miami Florida

6. Department of Medicine Memorial Sloan Kettering Cancer Center New York New York

7. Department of Medicine University of California San Francisco San Francisco California

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.33543

Reference49 articles.

1. Cancer statistics, 2019

2. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: prostate cancer version 1.2019. National Comprehensive Cancer Network;2019.

3. External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study

4. Development and Validation of a Novel Integrated Clinical-Genomic Risk Group Classification for Localized Prostate Cancer

5. Biochemical Outcome After Radical Prostatectomy, External Beam Radiation Therapy, or Interstitial Radiation Therapy for Clinically Localized Prostate Cancer

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic Impact of Prostate-Specific Antigen at 6 Months After Radiotherapy in Localized Prostate Cancer: An Individual Patient Data Analysis of Randomized Trials;Journal of Clinical Oncology;2024-06-20

2. Dynamic changes in PSA levels predict prognostic outcomes in prostate cancer patients undergoing androgen -deprivation therapy: A multicenter retrospective analysis;Frontiers in Oncology;2023-02-09